U.S. Online Retail and Ecommerce Stock News

Weyerhaeuser recently drew investor attention ahead of its past Q1 2026 earnings release, as analysts projected a sharp year-over-year drop in funds from operations and weaker quarterly profit. At the same time, analysts’ expectations for stronger funds from operations and earnings per share in fiscal 2026 and 2027 have raised questions about how short-term pressure might contrast with the longer-term outlook for the timber REIT. Next, we’ll examine how the expected Q1 2026 profit drop and...

Natera, Inc. recently reported Clinical Cancer Research data showing its Signatera molecular residual disease test helped older women with early-stage ER+/HER2- breast cancer use primary endocrine therapy instead of surgery, with testing done at baseline and then every 3–6 months. The study’s ability to identify patients who remained progression-free and to detect molecular signs of tumor progression before imaging highlights Signatera’s potential role in personalized treatment decisions for...

Garmin (GRMN) is on investor radars after recent share price swings, with the stock up about 14% over the past 3 months but showing a decline over the past month alongside mixed short-term returns. See our latest analysis for Garmin. At a share price of $232.01, Garmin’s short term momentum has cooled, with a 30 day share price return decline of 8.23%, even as the 90 day share price return of 14.38% and 3 year total shareholder return of 145.35% point to stronger performance over a longer...

Carpenter Technology (CRS) is back on investors’ radar after recent share price moves, with the stock closing at $394.15. That level is drawing fresh interest in its long term return profile. See our latest analysis for Carpenter Technology. The recent 6.3% 1 day share price return sits against a quieter 30 day share price return and a stronger 90 day gain of 25.2%, while the 1 year total shareholder return is very large and the 3 and 5 year total shareholder returns are each more than 8x...

TMC the metals company Inc. recently filed multiple shelf registrations, including ESOP-related offerings totaling roughly 21.1 million common shares and a broader universal shelf covering common and preferred shares, debt, warrants and units, soon after reporting a full-year 2025 net loss of US$319.84 million. At the same time, TMC highlighted progress toward a U.S. commercial production permit, outlined plans for a large processing and refining hub at the Port of Brownsville in Texas, and...

Why Recursion Pharmaceuticals is on investors’ radar today Recursion Pharmaceuticals (RXRX) has attracted attention after recent trading, with the share price at $3.07 and returns showing mixed performance over the past week, month and past 3 months. For investors tracking high risk biotech names, the company’s clinical stage drug discovery pipeline, revenue of $74.681 million, and market cap of about $1.5b provide context for assessing whether the current level looks appealing or...

In the past quarter, TransDigm Group reported a 13.9% year-on-year revenue increase and exceeded analyst expectations on both sales and adjusted operating income, which management described as a solid start to its 2026 fiscal year. This performance highlights the breadth of TransDigm’s installed base, with its proprietary components touching nearly all in-service aircraft across commercial and military aviation. Next, we’ll examine how TransDigm’s stronger-than-expected revenue and operating...

If you are wondering whether Axon Enterprise at around US$424.69 still offers value or has run ahead of itself, you are not alone. The stock has recently seen a 7% decline over the last week, a 21.7% decline over the last month and a 24.6% decline year to date, even though the 1 year return sits at 21.5% and the 3 year and 5 year returns are 90.4% and 191.7% respectively. Recent headlines around Axon have focused on product rollouts, contract wins with law enforcement agencies and ongoing...

In late March 2026, Honeywell announced a multi-year supplier framework agreement with the U.S. Department of War to expand production of critical defense technologies, alongside a large debt tender and a new AI-powered video and access-control collaboration between Honeywell Building Automation and Rhombus initially focused on North America. Taken together, these moves highlight Honeywell’s push to modernize its balance sheet while deepening exposure to defense demand and cloud-based,...

Grab Holdings (GRAB) stock is drawing attention after the company and WeRide started public operations of the Ai.R autonomous ride service in Punggol, opening a new chapter for Grab’s mobility platform. See our latest analysis for Grab Holdings. Despite the Ai.R rollout and recent corporate updates, momentum in Grab Holdings' share price has been weak. The 30 day share price return is 12.44% and the year to date share price return is 27.95%, while the 1 year total shareholder return of 20.61%...

Dividend freeze and business shift put UPS in focus United Parcel Service (UPS) is back on investors’ radar after CFO Brian Dykes outlined a 2026 dividend freeze, along with a move away from a low-margin Amazon segment to target higher-value customers. See our latest analysis for United Parcel Service. UPS shares closed at US$98.38 after a 3.61% 1-day share price return. However, the 30-day share price return of 15.16% and 1-year total shareholder return decline of 3.80% show that recent...

Dollar Tree recently entered into a US$500 million term loan credit facility maturing in March 2029, with interest tied to the Term SOFR Rate plus 1.00%, flexible prepayment, and covenants linked to leverage and fixed charge coverage ratios. The new financing, combined with ongoing investment in rebuilt and newly acquired distribution centers and cloud-based supply chain technology, underscores management’s emphasis on upgrading infrastructure and inventory management capabilities. We’ll now...

Why Rumble’s CFO change matters for investors Rumble (RUM) is reshaping its senior team, bringing in former Intel executive Mike Masci as CFO on March 31, 2026, while outgoing CFO Brandon Alexandroff shifts into an advisor role. For you as an investor, this type of leadership change can affect how the company balances cash needs, growth investments, and potential capital allocation decisions, including its AI and cloud infrastructure plans. See our latest analysis for Rumble. Rumble’s latest...

In March 2026, Rambus Inc. insiders, including executives Seraphin Luc and John Shinn, sold more than US$4.60 million of stock, prompting renewed scrutiny of management’s intentions and timing. This wave of insider selling has become a focal point for investors already watching semiconductor sector weakness and questioning how closely leadership’s actions align with Rambus’s long-term positioning in AI-focused memory solutions. We’ll now examine how this recent insider selling flurry...

If you are wondering whether Ascendis Pharma's share price still offers value after a strong run, the key is to look closely at what the current valuation actually reflects. The stock last closed at US$228.73, with returns of 6.1% over 7 days, a 2.0% decline over 30 days, 7.2% year to date, 51.0% over 1 year, 220.2% over 3 years and 73.7% over 5 years. Recent price moves have come alongside ongoing attention on Ascendis Pharma's pipeline progress and funding position, as investors reassess...

WEBTOON Entertainment Inc. recently announced that its regional CANVAS user-generated content services will be unified into a single global platform in 2026, supporting distribution in seven languages and introducing expanded creator monetization tools, analytics, and AI-assisted translation. This move signals an effort to lower language and distribution barriers for creators while deepening reader personalization, potentially increasing creator engagement and strengthening WEBTOON’s...

Recently, Deutsche Bank reiterated a Hold rating on Kimberly-Clark while Britain’s competition regulator began a phase 1 review of its US$3.40 billion Suzano joint venture, with a decision expected by May 28. At the same time, modest 2.5% organic sales growth and a five‑percentage‑point drop in free cash flow margin have raised fresh questions about Kimberly-Clark’s core profitability and capital needs. We’ll now examine how concerns over slowing organic sales and weaker free cash flow...

Capital raise potential and what it could mean for XPLR Infrastructure (XIFR) XPLR Infrastructure (XIFR) has filed a US$300 million shelf registration for its common units, giving the partnership flexibility to issue equity as funding needs or investment plans emerge. See our latest analysis for XPLR Infrastructure. The shelf filing comes as XIFR’s share price sits at US$10.62, with a 1 day share price return of 4.94% and a 1 year total shareholder return of 13.83%. The 3 year total...

MARA Holdings recently sold 15,133 Bitcoin between March 4 and March 25, 2026, raising about US$1.10 billion to repurchase roughly US$1.00 billion of its 2030 and 2031 convertible notes, cutting its Bitcoin holdings by around 28%. This large balance-sheet move, described by one hedge fund CIO as “distressed selling,” raises fresh questions about financial flexibility and sector-wide pressures in Bitcoin mining. Next, we’ll examine how this sizable Bitcoin liquidation and debt reduction...

NiSource (NI), a regulated natural gas and electric utility, is back in focus after recent share price moves that contrast a small decline over the past month with a stronger total return over the past 3 months and 1 year. See our latest analysis for NiSource. The recent 7 day share price return of 2.15% builds on a 90 day share price return of 11.73%. The 1 year total shareholder return of 18.68% sits alongside a 3 year total shareholder return of 85.44% and a 5 year total shareholder return...

Alnylam Pharmaceuticals has reported new clinical and real world data on its RNAi therapy vutrisiran in ATTR-CM, highlighting durable benefits in quality of life and reductions in advanced disease progression and mortality. The company has also shared pooled Phase 2 safety data for zilebesiran that supports its move into a global Phase 3 trial in hypertension and cardiovascular risk reduction. For investors tracking NasdaqGS:ALNY, this update centers on the company’s core RNAi franchise and...

Dollar General (NYSE:DG) has removed over 1,500 SKUs from its assortment as part of a broad simplification effort. The company is testing a new store format that pairs a leaner product mix with refreshed layouts. Existing locations are being renovated to align with the updated format and merchandising approach. Dollar General operates as a discount retailer focused on everyday essentials, often in smaller communities and value oriented shopping areas. The current SKU reduction and store...

Elanco Animal Health (NYSE:ELAN) is presenting at the World Vaccine Congress 2026. Senior leadership is discussing the company’s product development in animal vaccines. The appearance places Elanco alongside major global vaccine developers and industry experts. For you as an investor following NYSE:ELAN, this conference appearance ties directly to the company’s core focus on animal health products, including vaccines for livestock and companion animals. The World Vaccine Congress 2026 is a...

UP Fintech Holding Limited recently reported its fourth-quarter and full-year 2025 results, with Q4 revenue of US$175.57 million and net income of US$45.23 million, and full-year revenue of US$612.06 million and net income of US$170.9 million, all higher than the prior year. The sharp rise in basic earnings per share from continuing operations to US$0.96 for 2025, up from US$0.375 a year earlier, highlights a significant improvement in profitability. We will now examine how this strong...